Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Year-over-year book value per share growth
Latest
-3.71%
↓ 132% vs avg
Percentile
P72
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
11.43%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -3.71% |
| Q3 2025 | -14.11% |
| Q2 2025 | 80.07% |
| Q1 2025 | -10.03% |
| Q4 2024 | 61.06% |
| Q3 2024 | -10.89% |
| Q2 2024 | -9.90% |
| Q1 2024 | -12.40% |
| Q4 2023 | -8.03% |
| Q3 2023 | -6.34% |
| Q2 2023 | -6.63% |
| Q1 2023 | -5.79% |
| Q4 2022 | -31.35% |
| Q3 2022 | 56.95% |
| Q2 2022 | 199.23% |
| Q1 2022 | -57.02% |
| Q4 2021 | 50.04% |
| Q3 2021 | -40.24% |
| Q2 2021 | -27.75% |
| Q1 2021 | -17.08% |
| Q4 2020 | -25.10% |
| Q3 2020 | -12.50% |
| Q2 2020 | -14.46% |
| Q1 2020 | -14.20% |
| Q4 2019 | -10.15% |
| Q3 2019 | -10.33% |
| Q2 2019 | 432.26% |
| Q1 2019 | -26.76% |
| Q4 2018 | -27.51% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 0.00% |